GlassScriptPhysician profile
Amanda L Martin
NPI 1356538045
$4,137.24
in general payments reported to CMS, 2019-2025
32 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 90% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $586 · 2022: $308 · 2023: $629 · 2024: $832 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,230 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,230.29 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.14 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $570.03 | 2024-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $354.77 | 2023-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Novo Nordisk INC | $232.01 | 2022-2025 | Wegovy, Ozempic |
| Otsuka America Pharmaceutical, INC. | $218.74 | 2023-2025 | Rexulti, Abilify Maintena |
| Axsome Therapeutics, INC. | $195.48 | 2024-2025 | Auvelity |
| Glaxosmithkline, LLC. | $189.45 | 2021-2023 | Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $182.75 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $181.77 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.45 | 2021-2023 | Synjardy, Jardiance |
| Vanda Pharmaceuticals INC. | $152.89 | 2024-2025 | Fanapt |
| Supernus Pharmaceuticals, INC. | $129.81 | 2024-2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $103.90 | 2022-2023 | |
| Amarin Pharma, INC. | $99.02 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.29 | 2022-2025 | Trintellix |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $75.43 | 2025 | Jornay Pm |
| Lundbeck LLC | $75.25 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $74.05 | 2021-2023 | Mounjaro, Trulicity |
| Teva Pharmaceuticals USA, INC. | $72.18 | 2024 | Austedo Xr |
| Alkermes, INC. | $53.14 | 2025 | Aristada, Lybalvi |
| Pfizer INC. | $45.68 | 2021-2023 | |
| Bausch Health US, LLC | $33.97 | 2022-2023 | Aplenzin |
| Tris Pharma INC | $32.00 | 2025 | Dyanavel Xr |
| Mylan Specialty L.P. | $30.04 | 2022 | |
| Amgen INC. | $27.88 | 2023 | Repatha |
| Insulet Corporation | $23.19 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.18 | 2023 | |
| Idorsia Pharmaceuticals US INC | $17.60 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $16.02 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.61 | 2025 | Cobenfy |
| Esperion Therapeutics, INC. | $12.81 | 2021 | |
| Merck Sharp & Dohme LLC | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.